FDA Investigator Janet L Bowen

Janet L Bowen has conducted inspections on 125 sites in 14 countries as of 22 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
125
Last Inspection Date:
22 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Sweden, United States of America, Belgium, Switzerland, Germany, Australia, Serbia, United Kingdom of Great Britain and Northern Ireland, Czechia, Spain, Canada, Ireland, Mexico, Greece
FDA Investigators that have inspected at least one site in common with Janet L Bowen:
Aaron J Fox, Adam S Freeman, Alice C Silva, Alicia M Mozzachio, Allison E Sincek, Amy L Mccarthy, Anastasia M Shields, Andrew I Carr, Andrew J Barrowcliff, Andrew J Lang, Andria L Kuhlman, Angel K Sandhu, Angela E Glenn, Ann Marie Montemurro, Annemarie H Cochran, Annemarie Kleiza, Anthony Abel, Antionette N Johnson, Arie C Menachem, Ashar P Parikh, Ashley R Karns, Audrey Thereset Uy, Azza Talaat, Barbara Jwilimczyk Macri, Barry Rothman, Benjamin J Dastoli, Benjamin P Stewart, Brandon Bridgman, Brandy N Lepage, Brent M Dehaan, Brentley S Collins, Brian D Rogers, Brittany M Kershaw, Bruce H Mccullough, Camerson E Moore, Carla A Norris, Carla J Lundi, Carol Rivera Lopez, PhD, Carolyn A Renshaw, Catherine V Quinlan, CDR Ileana Barreto Pettit, CDR Sean T Creighton, Charles I Ann, Charles Yuanchia Kuo, PhD, Cheryl A Clausen, Christian D Lynch (CDL), Christian L Witkovskie, Christina K Theodorou, Christopher D Snyder, Christopher T Middendorf, Claire M Minden, Clinton D Priestley, Cody D Rickman, Craig P Seaborn, Craig T Rybus, Cynthia Jim, CSO, Cynthia L Rakestraw, D'arbra R Blankenship, Dale A Nyberg, Danial S Hutchison, Daniel J Brown, Daniel W Johnson, Darla J Christopher, Darren S Morgan, David B Wieneke, David J Gasparovich, David J Hafner, David L Chon, Dawn C Olenjack, Deborah M Trout, Dell S Moller, Denise M Digiulio, Dennis Cantellops Paite, Diane M Fresch, Diane R Mcdaniel, Dorathy M Eischen, Dr. Abhijit Raha, PhD, Dr. Mark J Seaton, PhD, Dr. Sriram Subramaniam, PhD, Dr. Willie F Vann, PhD, Dr. Zhou Chen (nmi), MD PhD, Edward R Kay, Eliezar Ramos, Elizabeth Ll Edwards, Emilie E Kahn, Emily E Krumel, Emily J Orban, Erin D Mccaffery, Farhana Khan, Frederick M Lochner, Gayle S Lawson, Gene D Arcy, Geneve M Maxwell, Geneve M Parks, Geoffrey K Kilili, George J Flynn, Helen B Ricalde, Helen Verdel, Holly J Wilson, Hugh M Mcclure, II, Jacob G Lutz, Jacqueline Mdiaz Albertini, James A Liubicich, James E Keller, PhD, James K Ireland, James R Evans, Jason D Werne, Jazmine N Still, Jeffrey A Sommers, Jeffrey D Meng, Jeffrey P Raimondi, Jennifer A Downie, Jennifer D Hollstrom, Jennifer L Gustavus, Jennifer M Heitz, Jie He, Joey V Quitania, John D Jaworski, Jonathan G Matrisciano, Jorge L Guadalupe, Jose A Lopez, Joshua C Schafer, Joshua S Hunt, Julianne C Mccullough, Julie D Bringger, Junho Pak, Justin A Boyd, Karen E D'orazio, Karen M Cooper, Karen M Kondas, Karyn M Campbell, Kathleen D Culver, Kathryn E Ogger, Kathryn J Mccarty, Katie L Korchinski, Katie L Penno, Keith J Mason, Jr, Kenneth E Felkley, Kristin M Abaonza, Laura M Howard, Laureen M Geniusz, Lauren N Smith, LCDR Debra Emerson, Leiyun Boone, PhD, Leslie A Paul, Leslie D Wagner, Lewis K Antwi, Lily Y Koo, Linda S Shook, Lindsey M Schwierjohann, Lindsey R Lyman, Lisa L Flores, Lisa M Marko, Louis Christy, Lucas B Leake, Luis Mburgos Medero, Maida Henesian (NMI), Marcia A Worley, Maribeth G Niesen, Marie F Morin, Mariza M Jafary, Mark E Parmon, Martha Sullivan Myrick, Martha T Olone, Mary E Storch, Matthew B Casale, Matthew J Gretkierewicz, Michael C Kennedy, PhD, Michael E Campbell, Michael E Clark, Michael J Schibi, Michael K Larson, Michael L Casner, Michael P Sheehan, Michael Schmitt, Michele Gottshall, Michele L Forster, PhD, Michele L Obert, Michele Perry Williams, Miguel A Martinez Perez, Mihaly S Ligmond, Mishelle L Harriger, Mra B Kamberem, Mra Davism, Mra M Barbosar, Mra Mcculloughj, Mra Narulaa, Myra K Casey, Nadeem I Chaudhry, Nancy A Saxenian Emmons, Nancy L Neiger, Nibin Varghese, MS, Nicholas A Violand, Nicholas L Paulin, Nimmy Mathews, Omotunde O Osunsanmi, Patricia H Dlugosz, Patrick C Klotzbuecher, Patsy J Domingo, Paul A Bonneau, Paula A Trost, Payne, Peter C Chow, Philip A Klimkewicz, Pifer, Prabhu P Raju, Qiao Y Bobo, Quynh H Strandberg, Ralph A Erickson, Raymond R Roy, PhD, Rebecca E Dombrowski, Rebecca Rodriguez, Regina I Stoltzfus, Regina T Brown, Richard K Vogel, Richard W Berning, Robert C Coleman, Robert Jennings, Robert M Barbosa, Robert R Barbosa, Roger F Zabinski, Ronald G Crawford, Rose Ashley, Said H Muse, Sanket N Patel, Sarah E Rhoades, Sarah M Napier, Sarah Rhoades, Saundrea A Munroe, Scott A Golladay, Sean R Marcsisin, Sergio Chavez (NMI), Shankar L Saha, Sidney B Priesmeyer, Simone E Pitts, Sneha S Patel, Stephanie Mangigian, MS/OSH, RN, Stephen D Brown, Stephen J Kilker, Steven D Kehoe, Susan M Jackson, Susan M Taylor, Susan P Bruederle, Susanna E Ford, Tamara M Kays, Thomas A Peter, Thomas J Arista, Thomas J Cosgrove, Thomas J Prigge, Thomas W Nojek, Timothy C Grome, Timothy K Lee, PhD, Tonnie L Carter, Tonya R Johnson, Tracey Asinjen Wiersma, Ucheabuchi Cchudi Nwankwor, Wen Ning Chan (Sally), Wendy G Tan, PhD, William D Tingley, Yiyue Zhang (nmi), PhD, Yonggang Wang, PhD, Yuan Chia Kuo, Yuesheng Ye, Yvesna C Blaise, Yvette Mlacour Davis

Janet L Bowen's Documents

Publish Date Document Type Title
December, 2019 FDA 483 Rentschler Biopharma Inc. - Form 483, 2019-12-13
July, 2013 EIR Mark Woyshville, M.D. - EIR, 2013-07-11
July, 2021 FDA 483 Response Baxalta US Inc. - Form 483R, 2021-07-23
May, 2021 FDA 483 Pharmacia & Upjohn Company LLC - Form 483, 2021-05-20
February, 2015 EIR Michael W Konstan MD - EIR, 2015-02-13
August, 2009 FDA 483 REESE PHARMACEUTICAL CO. - Form 483, 2009-08-04
September, 2015 FDA 483 RC Compounding Services, LLC - Form 483, 2015-09-14
May, 2021 FDA 483 Response Pharmacia & Upjohn Company LLC - Form 483R, 2021-06-11
March, 2013 EIR Ben Venue Laboratories Inc. - EIR, 2013-03-29
July, 2009 FDA 483 Akron Coating & Adhesives - Form 483, 2009-07-02
November, 2019 FDA 483 MassBiologics - Form 483, 2019-11-19
August, 2014 EIR Morton Salt, Inc. - EIR, 2014-08-20
May, 2015 FDA 483 Frontage Laboratories, Inc. - Form 483, 2015-05-29
January, 2010 FDA 483 Bonne Bell LLC - Form 483, 2010-01-20
May, 2015 EIR Frontage Laboratories, Inc. - EIR, 2015-05-29
July, 2014 FDA 483 VA Northeast Ohio Healthcare System IRB - Form 483, 2014-07-10
July, 2013 FDA 483 Mark Woyshville, M.D. - Form 483, 2013-07-11
December, 2019 EIR Rentschler Biopharma Inc. - EIR, 2019-12-13
November, 2012 EIR Cardinal Health - EIR, 2012-11-26
September, 2011 FDA 483 Ohio Valley Herbal Products, Inc. - Form 483, 2011-09-08
April, 2015 FDA 483 Charles River Laboratories Ashland, LLC - Form 483, 2015-04-08
April, 2015 FDA 483 Response Charles River Laboratories Ashland, LLC - Form 483R, 2015-04-28
July, 2021 FDA 483 Baxalta US Inc. - Form 483, 2021-07-01
June, 2010 EIR GOJO Industries, Inc - EIR, 2010-06-02
November, 2019 FDA 483 Response MassBiologics - Form 483R, 2019-11-19
December, 2013 FDA 483 GOJO Industries, Inc - Form 483, 2013-12-06
July, 2021 EIR Baxalta US Inc. - EIR, 2021-07-01
April, 2015 EIR Charles River Laboratories Ashland, LLC - EIR, 2015-04-08
May, 2011 FDA 483 Natural Essentials, Inc. - Form 483, 2011-05-06
December, 2013 EIR GOJO Industries, Inc - EIR, 2013-12-06
July, 2012 FDA 483 Natural Essentials, Inc. - Form 483, 2012-07-10
February, 2015 FDA 483 Michael W Konstan MD - Form 483, 2015-02-13
May, 2021 EIR Pharmacia & Upjohn Company LLC - EIR, 2021-06-10
May, 2009 FDA 483 Ben Venue Laboratories Inc. - Form 483, 2009-05-13
November, 2012 FDA 483 Western Reserve Health Education IRB - Form 483, 2012-11-09
March, 2014 EIR Bespak HC Limited - EIR, 2014-03-07

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more